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TREATED WITH RECIPROCAL TISSUE ANTIGEN**
The successful transplantation of autologous and isologous tissue has been
achieved for many years. However, the ability of an adult host animal to
reject a homograft from another adult animal of a different strain within
the same species has prevented successful homotransplantation in adult
animals. As early as 1953 Billingham and Sparrow' demonstrated that
living donor epidermal cells treated with immune serum were rendered
incapable of growth when grafted back onto the original donor. Shortly
thereafter, Voisin accelerated the homograft rejection of guinea pig A
transplants to guinea pig B by injecting the recipient with serum from
a rabbit actively immunized against the skin of guinea pig A. This passive
immunity to guinea pig A skin transplants could also be transferred to
guinea pig A and to guinea pig C. Further manifestations of a skin-specific
antigen were discovered when the rabbit developed alopecia, epithelium
thinning, and necrosis of superficial hair follicles. In 1960, this auto-allergic
phenomenon was confirmed by Chytilova et al.' Further indications that
the immunological response of the host to a homograft plays an important
role in determining the time survival of the homograft were noted when
Medawar demonstrated that specific leukocytes could immunize males and
females against thegraft; whenBollage0 detected antibodies in the recipient's
serum to the tissue extracts of the donor; when Hildemann demonstrated
that the survival time of a homograft could be decreased by the injection of
various numbers of the homologous spleen cells prior to the homotransplan-
tation; when Muller' induced the clouding of transplanted corneas by
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the intraperitoneal injection of donor skin into the recipient; when
Medawar" noted that the length of survival of a homograft varies inversely
with its size; when Gorer'1 noted an antibody titer increase following a
second incompatible graft; and when Stetsone8 noted that the white graft
immunity could be passively acquired by immune serum.
In the face of such preponderant evidence that the immunological
apparatus of the recipient was largely responsible for the inability of a
homograft to take, many attempts were made to completely destroy or
avoid the normal immunological apparatus of the host. Sublethal doses of
X radiation and antimetabolites were used in various manners with variable
results,"''' and thymectomy was found to be of dubious value "' in
prolonging the life of homografts. Lapp achieved good success in the homo-
transplantation of embryonic tissue" and Schubert demonstrated that people
with congenital agammaglobulinemia have a tendency to tolerate homo-
grafts for prolonged periods of time whereas people with acquired agamma-
globulinemia do not."
Perhaps the most common way to prolong homografts has been to inject
the recipient in its neonatal period with donor cells,' thereby rendering it
unable to form antibodies to this specific donor antigen in its adulthood
and unable to reject a graft from the donor. Although this last method has
been quite successful, many workers have noted that when newborn mice,
rats, or chicks are injected with homologous lymphoid tissue, many develop
the "runting syndrome"4'"' which is characterized by a failure to grow at
a normal rate, diarrhea,7"' anemia, positive direct Coombs test," spleno-
megaly"'"9, hepatomegaly,9"'8 and involution of their lymphoid tissue.""4"'
This phenomenon would certainly make most workers agree that an appli-
cation of this process to humans could be potentially dangerous and unwise.
In 1961, Howard' demonstrated that even the immunologic reactivity of
adult mice could be depressed by the parental strain spleen cells and in
1962, Binete noted that the graft produces large immunologically competent
mononuclear cells. Further evidence of graft versus host reaction was
demonstrated by the vascular changes that accompany a homograft rejec-
tion. The graft initially receives its blood supply from three sources: 1) a
direct connection of the graft's vessels with the host's vessels; 2) the
vascularization of the graft's dermal tissue by the host's ingrowing vessels;
3) by the ingrowth of recipient vessels into endothelial vessels of the graft.'7
Within two weeks after the transplantation, rouleaux accumulate in the
blood vessels of the graft, thrombi are formed, and the capillaries are rup-
tured leading to widespread hemorrhage, necrosis, and rejection of the
graft." The formation of the rouleaux, the destruction of host blood vessels
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proliferating into the graft, and the inverse relationship between the graft
survival time and its size as noted by Medawar,'3 might very well indicate
a graft reaction against the recipient.
The survival time of grafts is even affected by the sex of the donor or
recipient as revealed by Eichwald's finding"'u in 1955 and 1961 that intra-
strain grafting in A/Jax mice was successful from male to male and from
female to female, but that isologous grafts from male to female were
generally rejected. In 1957, Peer"' noted that grafts from grandfathers and
from fathers were rejected by infants, whereas mothers' grafts to infants
were prolonged. In 1958, Voisine noted that female grafts on males had
shorter survival times than did male grafts on females.
The graft survival time of mice is also affected by the histocompatible
gene difference between the donor and recipient. Autologous and isologous
grafts of well-inbred mice are readily accepted as were the grafts from
male F1 hybrids of reciprocal parentage in Eichwald's work of 1958.' He
noted, however, that a second-set response occurred when an F1 male was
grafted from a male of pure strain of one of its parents. This work demon-
strates that rejection may be the result of a very slight histocompatible
gene difference between the donor and host and reveals the difficulty mani-
fest in attempting to find a donor type completely compatible to the host
and vice versa.
If one is to achieve success in transplanting tissue between adult animals,
it would seem that one must eliminate or depress both the ability of the
host to react against the homograft and the ability of the graft to react
against the host. One way to prevent an adult animal from reacting against
an antigen is to completely overwhelm the immunological apparatus of that
animal with the antigen, producing immunological paralysis in the manner
that Felton rendered mice incapable of forming antibodies to the pneumo-
coccal capsular polysaccharide.M As early as 1925 Rhodes prolonged the
survival time of homografts by the injections of skin antigen into the host.'
In 1952 Allen succeeded in prolonging skin graft survival from 7 to 23 days
in rabbits by injecting into the recipient products of donor skin treated
by the quick-freeze method.' He and Randall'2 also noted at this time that
ACTH did not prolong the survival time of skin homografts nor did Allen
find that ACTH potentiated the desensitization process. In 1954 Werder
was able to produce prolongation of skin graft survival by applying consecu-
tive homografts to mice, thereby indicating that perhaps the immune
response of the host could be diminished or eliminated."' Assuming that the
effect was immunological paralysis, Hardin and Werder"" then induced
prolongation of skin grafts in CFW mice by subcutaneous injections of skin
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extract into the host. Some of the grafts were still viable at the end of six
months. In 1956, Billingham et aL prolonged the survival of homografts
for several days by injecting strain A or CBA mice with reconstituted
suspensions of lyophilized homologous tissues prior to homotransplantation6
and in 1952, Stark prolonged the life of homografts in adult rabbits by at
least 100 per cent by the subcutaneous injections of homologous whole
blood prior to homotransplantation.'4 By using extracts and red blood cells
to produce immunological paralysis, one avoids producing the runting
syndrome, which would be one of the major hazards were attempts made to
produce tolerance to grafts from a specific donor in newborn children.
However, one cannot avoid introducing immunologically competent cells
in a homotransplant unless the donor has also been immunologically para-
lyzed prior to the homotransplantation.
The experiment described in this paper consequently was designed to
achieve suppression of both normal grafting responses: that of the host
against the graft, and that of the graft against the host. In 1962 Pomeroy
and Crelin achieved permanent takes in skin homotransplants from strain
A/SG mice onto strain CBA/SG mice after treating strain A/SG mice
with CBA/SG mice skin antigens before transplanting and strain CBA/SG
mice with strain A/SG skin antigens before and after homotransplan-
tation.'1 In this experiment, both donor and host were treated with homo-
logous antigenic preparation in order to prevent the graft from rejecting
the host and the host from rejecting the graft. Young male mice were
utilized in order to avoid any rejections because of sex variation and to
avoid the possibility that older mice might not be capable of rejecting a
homograft as readily as young mice, a phenomenon observed by Medawar
and Sparrow, but not by Krohn.' Mice strains A/SG, A/Hej, and
CBA/SG were utilized because of Barnes' work' which ruled out the
possibility of natural acceptance of homografts between these strains.
Pooled homologous antigenic preparation was utilized in order to achieve
an antigenic preparation of each strain that would be representative of
each mouse in that respective inbred strain. The value of pooled antigenic
preparations was evident in the work of Cannon in 1958 when he demon-
strated that induced tolerance was "not exclusively individual specific"' and
by Lengerova in 1960, who concluded that antigen prepared from at least
40 donors would be necessary in order to produce universal transplantation
immunity or tolerance.'
These respective homologous antigenic preparations were stored in 30 ml.
aliquots in a frozen state and thawed as needed, in keeping with the work
of Darcy in 1955 in which he demonstrated that frozen, thawed tissue still
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retains its antigenicity. The thawed product was then preserved with a
1/10,000 tincture of merthiolate in order to avoid nonspecific graft survival
time which has been shown by Billingham to occur when phenol is used as
a preservative.' The present work is an elaboration and extension of this
preliminary study.
MATERIALS AND METHODS
A total of 128 young adult male mice of the inbred strains CBA/SG*, A/SG*,
and A/HEJ** were used as donors and/or recipients of homologous skin grafts
after they had been treated three times a week for variable periods with varying
doses of a homologous antigenic preparation (HAP)t as follows:
1. CBA/SG antigen was prepared by homogenizing skin, liver, kidney, and muscle
of male mice from an inbred CBA/SG strain on a Virtis 23 Homogenizer fitted with
an adapter to utilize Marco Stainless Steel Blades, No. 16-108. The homogenate
was diluted to a 50 g/100 ml. suspension with 0.85 g/100 ml. ice cold saline. After
centrifugation, the supernatant was frozen in 30 ml. aliquots in No. 2320 vaccine
bottles and thawed as needed. The thawed product was preserved by adding tincture
of merthiolate to a 1/10,000 concentration.
2. A/SG antigen was prepared in the same manner as CBA/SG antigenic prepara-
tion except that only muscle and skin of male mice of an inbred A/SG strain
were used.
3. A/Hej antigen was prepared exactly in the same manner as No. 2. The
mice were grouped as follows (Table 1):
Group I: Male mice of the strains of CBA/SG, A/SG, and A/Hej received no
treatment or homografts. Skin sections were examined after preparation for study
by light microscopy.
Group II: Five mice of the CBA/SG strain received ten homografts from five
A/SG mice. Mice of this group were used to study the fate of the grafts with no
treatment.
Group III: Five mice of the CBA/SG strain received five homografts from five
A/SG mice after both donor and recipient had received 13 0.2 ml., 16 0.3 ml., and
6 0.6 ml. intraperitoneal injections of tincture of merthiolate.t Recipients received eight
0.3 ml. injections of 1/10,000 tincture of merthiolate post-operatively. The grafts in
mice of this group were examined macroscopically and microscopically.
Group IV: Five mice of A/SG strain received ten homografts from five CBA/SG
mice after the donors had received 16 0.3 ml. injections of HAP.t
Group V: Four mice of the CBA/SG strain received eight homografts from four
A/SG mice after the recipients had received 16 0.3 ml. injections of HAP.
* From the colony of Dr. W. U. Gardner at the Yale University School of Medicine.
** Purchased from the Jackson Memorial Laboratories, Bar Harbor, Maine.
tHomologous Antigenic Preparation (HAP) in this project refers to that antigenic
preparation from an inbred strain of mice that is believed to have at least the same
antigenic components as the homologous skin grafts.
t All injections of tincture of merthiolate (TM) or HAP were intraperitoneal at
a rate of three injections per week.
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Group VI: Six mice of the CBA/SG strain and three A/Hej mice received 12
and 6 isologous grafts respectively.
Group VII: Five mice of the CBA/SG strain received five homotransplants from
five A/SG strain mice after both donor and recipient had received 13 0.2 ml. and
6 0.3 ml. injections of HAP. Recipients received 11 0.3 ml. injections of HAP post-
operatively.
Group VIII: Two CBA/SG strain mice received homografts from two A/SG
strain mice after both donor and recipient had been treated with 13 0.2 ml. and
5 0.3 ml. injections of HAP. Recipients received 11 0.3 ml. injections of HAP
post-operatively.
Group IX: Thirty CBA/SG mice received 60 homografts from 30 A/SG mice
after both donor and recipient had been given 16 0.3 ml. injections of HAP. Recipients
were treated with 3 0.6 ml. injections of HAP post-operatively.
Group X: Twenty-eight CBA/SG mice received 56 homografts from 28 A/Hej mice
after both donor and recipient had received 16 0.3 ml. injections of HAP. Recipients
received post-operatively 3 0.6 ml. injections of HAP.
Group XI: Twenty-six A/SG mice received 52 homografts from 26 CBA/SG
mice after both donor and recipient were given 16 0.3 ml. injections of HAP.
Group XII: Twenty-two mice of the A/Hej strain received 44 homografts from
22 CBA/SG strain mice after both donor and recipient had received 16 0.3 ml.
injections of HAP.
Group XIII: Six CBA/SG mice received six homografts from six A/SG mice
after both donor and recipient had been given 13 0.2 ml., 6 0.3 ml., and 6 0.6 ml.
injections of HAP.
Skin homotransplantation was performed on donor and recipient mice under sodium
amytal-ether anesthesia in a manner similar to that developed by Gross and Gottfried.2'
Anesthetized mice were placed on an operating board so that all extremities were
held down by elastic bands. All hair was then shaved off the dorsum of each animal
with a Progienic Electric Clipper, Model No. 11, utilizing a No. 50 Unitary Cutting
Assembly. The skin was then washed with 100 per cent alcohol and a 3-inch strip
of Surgical Tape, No. 1530, produced by the Minnesota Mining and Manufacturing
Company, was applied firmly to the backs of the two animals. The tape, still applied
to the skin, was pinched in the midline and two full-thickness grafts were then
produced with a Weck Stainless Steel Skin Graft Punch (Fig. 1). The two skin
grafts of each animal were then immediately transferred to the graft bed produced
in the reciprocal animal after penicillin powder and a drop of streptomycin (.0011
gm/ml.) had been instilled into the bed (Figs. 2 and 3). Each animal was both a
donor and a recipient of two skin transplants. This enabled a determination of whether
a rejection was due to an infected graft or to inadequate treatment. A four-inch strip
of Surgical Tape, No. 1530, was then spread over the tape already existing on the
dorsum of the animal, covering and adhering to the tape affixed to each graft,
thereby holding each graft in place. The tape was then drawn tightly together
girding the animal just proximal to the lower extremities (Fig. 4). Gauze was
placed over the graft areas and then adhesive tape was placed over the gauze and
the surgical tape to protect the graft. The animals were housed in groups of 2 or 3
throughout the rest of the project.
In some groups, (see Table 2) each animal received two homologous skin trans-
plants, whereas in other groups, the animals received two isologous skin grafts or one
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FIG. 1. Fold of shaved dorsal skin with surgical tape (arrow) situated between the jaws of a Weck
skin punch so as to produce two full-thickness skin grafts from a strain CBA/SG mouse.
FIG. 2. A CBA/SG strain mouse after two full-thickness skin grafts were removed. Arrows indicate the
two oval holes in the skin.
FIG. 3. A CBA/SG strain mouse after two full-thickness homologous skin grafts (arrows), with tapes
affixed, have been laid into the graft beds. The grafts were from a strain A/SG mouse.
FIG. 4. A strain CBA/SG mouse with tape wrapped around its abdomen after two skin grafts were
applied.FIG. 5. A strain CBA/SG mouse with two 175-day-old isografts (arrows). Note lack of pigmentationi of
the hairs of the isografts.
FIG. 6. A CBA/SG strain mouse after the hair had been shaved off its back to expose an intact 175-
day-old homologous skin graft (arrow) from an albino strain A/SG mouse. Both donor and recipient had
been treated with injections of HAP prior to the homotransplanitatioln. The recipient was treated with
HAP injections post-operatively.
FIG. 7. Growth of white hair from a 120-day-old full-thickness skini hlomiograft from a straini A/SG on
ani agouti strain CBA/SG mous_. Both donior and recipient were treated with injectionis of HAP prior to
homotransplantation. Recipients received injections of HAP following transplantationi.
FIG. 8. A strain A/Hej mouse with an intact 175-day-old homograft (arrow) from a CBA/SG strain
mouse. Note that the originally agouti homograft is devoid of pigment. Both donor and recipient were
treated with injectionis of HAP prior to the homotransplan-tatioil.FIG. 9. Section of normal skin from an untreated CBA/SG mouse. (E) epidermis; (H) pigmented
hair; (F) hair follicles. (X 100)
FIG. 10. Section of pigmented hair (arrow) from an untreated strain CBA/SG mouse. (X 1100)
FIG. 11. Section of skin from ain albino A/SG strain mouse (E) epidermis; (H) hair without pigment;
(F) follicles. (X 180)
FIG. 12. Higher magnificationi of a !)ortion of the skin shown in Figure 11. Hair wvithout pigmenit
(arrow); (S) Sebaceous gland. (X 780)FIG. 13. Section of a CBA/SG skin isograft which has lost most of its pigment. (E) epidermis;
(H) hair; (F) follicle. (X 160)
FIG. 14. Higher magnification of portion of skin isograft shown in Figure 13. Hair without pigment
(arrow); (S) Sebaceous gland. (X 780)
FIG. 15. Section of a 32-day-old homograft from a strain A/SG mouse to a CBA/SG strain mouse.
Both donor and recipient received injectionis of HAP before homotransplantation. Recipients were treated
with injections of HAP following homotransplantation. (E) epidermis; (H) hair; (F) follicle. (X 290)
FIG. 16. Higher magnification of a portion of the homograft shown in Figure 15. Hair without pigment
(arrow) ; (S) sebaceous gland. (X 780)Skin homograft survival I POMEROY
homologous skin graft and one autologous skin graft in order to determine the
degree to which each strain was inbred and whether the grafting procedure was
effective.
RESULTS
After transplantation, the bandages were removed at varying lengths of
time from representative animals in some groups to note the changes in the
grafts. The animals were then sacrificed or the bandages were replaced until
the grafts were sufficiently accepted macroscopically and at that time, the
bandages were removed from all mice within the respective group.
Viability of the homografts was judged in accordance with the macro-
scopic characteristics of the isologous grafts in Group VI which were all
accepted, and necrosis of the homografts was judged in accordance with
the characteristics of Group II in which neither the donor nor the recipient
was treated with HAP (homologous antigenic preparation) or tincture
of merthiolate. By this method, grafts which appeared soft, light pink, and
somewhat waxy after the removal of the epidermal cap, along with the
removal of the protective tapes, were judged to be viable. Those grafts
that were hard, edematous, grossly infected, of cheesy appearance, or dark
pink were judged to be necrotic.
Both homologous and isologous grafts from the agouti CBA/SG strain
maice were devoid of pigment when the protective tapes were removed.
The areas surrounding the grafts were pigmented and, in rare instances
some pigment extended into a graft. Lack of pigmentation persisted in
these grafts until the recipients were sacrificed.
No hair grew in any of the homografts in Groups II-V and IX-XII.
When a homograft was rejected belatedly by a recipient that had been
treated with HAP, a shallow punched-out ulcer was produced in the graft
bed which quickly healed by secondary closure. Within several months
after this delayed rejection, the scar had contracted to such an extent that
it was almost as difficult to detect as that produced in the initial rejection
of a homograft by an untreated mouse.
No infected grafts were included in the results nor were grafts on
animals that removed tapes and grafts before the time determined for the
tape removal. After different intervals, representative grafts were photo-
graphed and fixed in modified Bouin's solution, embedded in paraffin,
sectioned serially at 7, and stained with hematoxylin and eosin.
Group I: The microscopic appearance of the normal skin from the
strains of mice used in the experiment are shown in Figures 9-12.
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Group II: When the protective tapes were removed 11 days after homo-
transplantation, edematous host tissue surrounded the soft, friable, grossly
necrotic homografts of all the mice. The grafts were completely rejected
by 13 days. Within two months, the scar tissue had constricted so that
the locus of the original graft site was barely discernible.
Group III: When the protective tapes were removed 38 days after homo-
transplantation, all graft beds were lined with fibrous tissue and no grafts
were found.
Group IV: When the protective tapes were removed 46 days post-
operatively, seven of the homografts were pink, soft and viable. These
grafts persisted through 80 days. At 90 days, four animals still had viable
grafts and by 120 days only two of the three remaining mice had viable
grafts, two mice having been sacrificed at 89 days post-operatively. These
two grafts persisted through 150 days, but were replaced by a shallow
punched-out ulcer at 173 days.
Histological sections revealed the homografts to be largely composed of
a collagen tissue with no viable glands or hairs.
Group V: When the protective tapes were removed 46 days post-
operatively, the grafts were extremely friable and surrounded by edematous
host tissue. By 55 days, all grafts had been rejected, leaving a bed of
fibrous tissue.
Group VI: When the protective tapes were removed seven days post-
operatively, all isologous grafts were viable and remained intact until all
the recipients were sacrificed at 175 days post-operatively. The grafts were
initially soft and pink. Within two weeks, white hair grew from all grafts,
irrespective of the original color of the donor or recipient (Fig. 5).
CBA/SG mice are agouti and A/SG mice are white.
Histological sections revealed a complete absence of pigment in the hair
(Figs. 13 and 14) and skin of all isologous skin transplants, except for
a few rare occasions when pigment deposits were detected in the isologous
CBA-SG full-thickness skin transplants.
Group VII: When the protective tapes were removed at 20 days, two of
the grafts were soft, pink, and viable. Hair growth became grossly evident
within two months. These grafts persisted for 126 days at which time the
recipients were sacrificed (Fig. 7).
Histological sections revealed numerous viable hair follicles, without
pigment, and viable sebaceous glands within the full-thickness skin homo-
grafts.
40
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Group VIII: When protective tapes were removed at 20 days, both
grafts were soft, pink, and viable. At 32 days post-operatively, white hair
grew from the homografts. Recipients were sacrificed at this time.
Histological sections revealed numerous viable hair follicles, lacking
pigment, and viable sebaceous glands within the full-thickness skin homo-
grafts (Figs. 15 and 16).
Group IX: When the protective tapes were removed 45 days -post-
operatively, 35 homografts on 26 recipients were pink, soft, and grossly
viable; 14 homografts were absent; and 8 homografts on 4 recipients were
grossly infected. By 60 days, 3 animals had died and 2 animals had lost
both their homografts, leaving a total of 28 intact homografts on 19 mice
and 4 mice with no intact homografts. At 175 days (Table 2) 16 homo-
grafts were still on 13 of 19 animals (Fig. 6). All recipients were sacrificed
at this time.
Microscopic sections revealed occasional viable sebaceous glands but no
hair growth.
Group X: When the protective tapes were removed 45 days post-
operatively, 41 pink, soft, viable grafts were intact on 22 mice; 8 homo-
grafts on 4 mice were grossly infected; and 3 grafts were absent. At 60
days, 40 grafts were intact on 21 of 22 mice (Table 2). At 175 days post-
operatively 24 homografts on 14 of 18 mice were intact, at which time all
recipients were sacrificed.
Microscopic sections revealed occasional sebaceous glands but no hair.
Group XI: Six mice developed alopecia and a smooth waxy epidermis
during treatment. With the continuation of treatment, the hair grew back
and the epidermis assumed its normal appearance, similar to the results
observed by Voisin.'
When the protective tapes were removed 45 days post-operatively, 41
viable homografts were intact on 21 mice; 1 homograft was absent; and
10 homografts on 5 animals were grossly infected. At 90 days post-
operatively, 29 homografts were intact on 21 of 21 recipients. At 150 days,
19 homografts were intact on 15 of 19 mice (Table 2). When the animals
were sacrificed at 175 days, 13 homografts were intact on 13 of the 17
remaining mice.
Microscopic sections revealed occasional viable sebaceous glands but
no hair.
Group XII: When the protective tapes were removed 45 days post-
operatively, 36 soft, pink, viable homografts were intact on 22 of 22 recipi-
ents; 9 homografts were absent; and 5 homografts were infected. At 90
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days, 31 homografts were intact on 21 of 22 mice and when all the mice
were sacrificed at 175 days, 16 homografts were intact on 13 of the remain-
ing mice (Fig. 8).
Microscopic sections revealed occasional viable sebaceous glands but
no hair.
Group XIII: When the protective tapes were removed at 30 days, 6
viable homografts were intact on the 6 recipients. Two homografts grew
hair within two months. Five animals with viable homografts were sacri-
ficed at 22, 22, 22, 129, and 129 days respectively. The sixth homograft
remained intact until 452 days when the recipient was sacrificed.
Histological sections revealed numerous viable hair follicles, lacking
pigment, and viable sebaceous glands within the full-thickness skin homo-
grafts. In one homograft, the white hairs persisted despite the necrosis of
the rest of the skin homograft.
DISCUSSION
All homografts to untreated animals were completely rejected within 13
days. The survival time of the homografts in which only the donor had
received HAP (homologous antigenic preparation) prior to homotrans-
plantation, persisted to 173 days. However, these homografts were largely
composed of collagenous tissue with no viable glands or hairs. This was
in contrast to the growth of hair and sebaceous glands in the homografts in
which both donor and recipient had been treated with HAP for extended
periods of time before and after homotransplantation. Thus, treatment of
both the donor and the recipient with HAP before and after homotrans-
plantation might be more than additive since the results exceed those
anticipated from treating just the donor or recipient.
Hair growth was noted only in those groups in which both donor and
recipient were initially treated with very small amounts of HAP in
addition to the large doses of HAP prior to the homotransplantation, and
in which the recipient was treated with large doses of HAP post-
operatively. This may indicate that an extensive period of sensitization
is necessary before one can induce complete immunological tolerance or
paralysis in an animal. It may also indicate that tolerance is not as readily
induced for the skin appendages as it is for the rest of the full-thickness
skin grafts.
The observations by Conway' that autologous skin grafts tend to lose
their pigmentation also holds true for isologous and homologous grafts
which, in the present work, were devoid of pigment in the skin and its
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appendages. This loss of pigment in a graft may indicate that the melano-
cytes do not survive the initial deprivation of blood supply or that they
migrate from the graft.
The presence of hair in one homograft in which the hair follicles and
sebaceous glands were either necrotic or absent indicates that the presence
of hair is not necessarily a sign that the homograft is viable. Conversely,
the survival of sebaceous glands and hair follicles within many of the
homografts which lack hair in the present experiment also confirms that
the presence of hair is not a criterion for survival of a homograft, as
observed by Billingham.'
Conway's study' indicates that autologous graft hair growth is grossly
visible at three weeks. The results of the present study indicate that
isologous graft hair growth was grossly visible at approximately two weeks
and the homologous hair growth was grossly visible at 32 days.
SUMMARY
Reciprocal immunological tolerance or paralysis was induced by treating
both donor and recipient mice for varying periods of time with injections
of homologous antigenic preparation (HAP). An antigenic preparation of
each inbred strain was produced by homogenizing tissues of many mice
of each respective strain after the purity of each respective strain of mice
had been confirmed by the complete success of isologous grafting.
One hundred and twenty-eight young adult male mice of the inbred
strains A/SG, CBA/SG, and A/Hej were used as donors and/or recipients
of homografts after they had been treated with HAP (homologous anti-
genic preparation) for varying lengths of time. The recipients in some
groups were treated with HAP after homotransplantation. Another 21
mice were used as controls.
In this study, the following results were observed: (1) Isologous and
homologous CBA skin grafts are devoid of pigment. (CBA/SG strain mice
are agouti.) (2) Hair first appeared in isologous grafts at approximately
two weeks, whereas it first appeared in homologous grafts at approxi-
mately four and one half weeks. (3) Full-thickness skin homografts sur-
vived up to 173 days following treatment of only the donor with HAP
prior to the homotransplantation. (4) Full-thickness skin homograft sur-
vival time was prolonged as much as 452 days by treatment of both donor
and recipient with HAP prior to the homotransplantation. (5) Small
sensitizing injections of HAP to both donor and recipient prior to the
routine pre-operative injections of HAP and injections of HAP to the
recipient post-operatively are prerequisites for homograft hair growth.
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(6) Hair growth is not necessarily indicative of a completely viable homo-
graft. (7) Lack of hair growth does not necessarily indicate that the rest
of the homograft is not viable. (8) Full-thickness skin graft infection rates
are higher in homologous than in isologous grafts.
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